Patents
Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210)
08/2000
08/10/2000WO2000045840A1 Compositions and methods for treating and preventing pathogenic bacterial infection based on the essential role of dna methylation in bacterial virulence
08/10/2000WO2000045839A2 A method for selecting and producing vaccine and diagnostic preparations
08/10/2000WO2000045838A1 A METHOD FOR TARGETED DEGRADATION OF INTRACELLULAR PROTEINS IN VIVO OR $i(EX VIVO)
08/10/2000WO2000045836A1 Uses of thank, a tnf homologue that activates apoptosis
08/10/2000WO2000045835A1 Vascular endothelial growth factor-2
08/10/2000WO2000045633A1 Transgenic animal showing vascular tissue-specific expression of angiotensin ii2 receptor
08/10/2000WO2000037619A3 Mutant epoxide hydrolases
08/10/2000WO2000036109B1 Maize rad2/fen-1 orthologues and uses thereof
08/10/2000WO2000034335A3 'death domain' containing receptors
08/10/2000WO2000033084A3 Arrays of organic compounds attached to surfaces
08/10/2000WO2000029008A3 Hiv-specific t-cell induction
08/10/2000WO2000028014A3 Plastid transformation of solanaceous plants
08/10/2000WO2000026389A3 Dna comprising rice anther-specific gene and transgenic plant transformed therewith
08/10/2000WO2000026368A3 Therapeutic antiangiogenic endostatin compositions
08/10/2000WO2000026239A3 $i(chlamydia) antigens and corresponding dna fragments and uses thereof
08/10/2000WO2000025827A3 Dna molecules encoding muc-1 and use thereof in tumor vaccination
08/10/2000WO2000024937A3 Parallel methods for genomic analysis
08/10/2000WO2000024915A3 Plant raffinose synthase homologs
08/10/2000WO2000024911A3 Human phospholipases
08/10/2000WO2000024773A3 Inhibition of transglutaminase-mediated microbial infection of a mammalian host
08/10/2000WO2000023583A3 p53 BINDING AREAS
08/10/2000WO2000020604A3 Oxidoreductase molecules
08/10/2000WO2000016746A8 Immunogenic liposome compositions
08/10/2000WO2000015779A3 Molecular cloning using rolling circle amplification
08/10/2000WO2000014219A9 Peptide nucleic acid-oligoadenylate chimeric molecules
08/10/2000WO2000012715A9 Modification of plant fibres
08/10/2000WO2000012707A9 14926 receptor, a novel g-protein coupled receptor
08/10/2000WO2000010599A8 IMMUNOGENIC β-PROPIONAMIDO-LINKED POLYSACCHARIDE PROTEIN CONJUGATE USEFUL AS A VACCINE PRODUCED USING AN N-ACRYLOYLATED POLYSACCHARIDE
08/10/2000WO2000010588A9 Epidermal growth factor receptor antagonists for treating hypersecretion of mucus in the lungs
08/10/2000WO2000004190A9 Evolution of whole cells and organisms by recursive sequence recombination
08/10/2000WO2000003699A3 Drugs containing phosphoric acid derivatives as active ingredient and their use
08/10/2000WO2000002997B1 Transgenic mouse expressing green fluorescent protein in astrocytes
08/10/2000WO2000000593A3 Sphingolipid-desaturase
08/10/2000WO1999066072A3 Methods for treating a neurological disease by determining bche genotype
08/10/2000WO1999063086A8 Insulin-like growth factor binding protein-3 variants
08/10/2000WO1999058713A3 Method for detecting microorganisms in products
08/10/2000WO1999008706A8 Recombinant porcine adenovirus vector
08/10/2000WO1999006547A3 Products of gene and protein therapy of cystic fibrosis and inducers of a glutathiones-s-transferase
08/10/2000DE19906169A1 Testkit und Verfahren zum quantitativen Nachweis von gentechnisch veränderter DNS in Lebensmitteln mittels fluoreszenzgekoppelter PCR Test kit and method for the quantitative detection of genetically modified DNA in food by fluorescence-coupled PCR
08/10/2000DE19905128A1 New human antibiotic peptides, useful for treating microbial infections, particularly when incorporated in wound dressings, also related nucleic acid
08/10/2000DE19905069A1 Nucleinsäuremoleküle codierend Alternansucrase Nucleic acid molecules encoding alternansucrase
08/10/2000DE19904794A1 Verfahren zur Verbesserung des Primärstoffwechsels von Säugerzelllinien A method for improving the primary metabolism of mammalian cell lines
08/10/2000DE19904754A1 Plant guard cell-specific regulatory cis-active element useful for promoter constructs and for identification of components of guard cell signal pathways comprises specific sequences
08/10/2000DE19904267A1 Verfahren zur Anreicherung von Tumorzellen aus einer Körperflüssigkeit und dazu geeigneter Kit A process for the enrichment of tumor cells from a body fluid and to a suitable kit
08/10/2000DE19903920A1 Sebozyten, Sebozyten-Zellinie und deren Verwendungen Sebocytes, sebocytes cell line and their uses
08/10/2000DE19903507A1 Verfahren zur Herstellung endotoxinfreier oder an Endotoxin abgereicherter Nukleinsäuren und deren Verwendung Process for the preparation endotoxin or endotoxin-depleted nucleic acids and their use
08/10/2000CA2492661A1 Non-stochastic generation of genetic vaccines and enzymes
08/10/2000CA2371794A1 Human antibiotic proteins
08/10/2000CA2362239A1 Novel rgs-containing molecules and uses thereof
08/10/2000CA2362126A1 B7rp-1 polypeptides
08/10/2000CA2361923A1 Multichannel control in microfluidics
08/10/2000CA2361838A1 Method of treating cancer by restoration of pp32 function
08/10/2000CA2361703A1 Tryptophan synthase as a site of herbicide action
08/10/2000CA2361678A1 Method of modulating metabolite biosynthesis in recombinant cells
08/10/2000CA2361654A1 Use of fluorescent molecular beacons in the detection of methylated nucleic acids
08/10/2000CA2361615A1 The use of vascular endothelial growth factor 2 antagonist in the treatment of an injury to or disorder of an eye
08/10/2000CA2361599A1 Methods of utilizing the tt virus
08/10/2000CA2361459A1 Use of cationic lipids to generate anti-tumor immunity
08/10/2000CA2361191A1 Gene repair involving the induction of double-stranded dna cleavage at a chromosomal target site
08/10/2000CA2361038A1 Pigment protein from coral tissue
08/10/2000CA2360942A1 Preparations for preventing and/or treating a tissue change of mesenchymal origin
08/10/2000CA2360929A1 Genomic analysis method
08/10/2000CA2360893A1 Tau-conotoxin peptides
08/10/2000CA2360878A1 Gene repair involving excision of targeting dna
08/10/2000CA2360858A1 Genetically engineered retroviral vector particles capable of infecting non-dividing cells
08/10/2000CA2360834A1 Candida albicans srb-7
08/10/2000CA2360796A1 Improved helper dependent vector system for gene therapy
08/10/2000CA2360753A1 Method of improving the primary energy metabolism of mammalian cell lines
08/10/2000CA2360741A1 Protein with cell proliferation and cell division modulating activity and dna encoding such protein
08/10/2000CA2360731A1 Modification of lignin composition of gymnosperms
08/10/2000CA2360684A1 Method for inducing differentiation into adipocytes, compounds controlling such differentiation and method of screening for same
08/10/2000CA2360670A1 Production of biomedical peptides and proteins in plants using transcomplementation systems
08/10/2000CA2360640A1 Genetic and epigenetic regulation of abc transporters and ect0-phosphatases for the modulation of drug resistance
08/10/2000CA2359469A1 Compositions and methods for treating and preventing pathogenic bacterial infection based on the essential role of dna methylation in bacterial virulence
08/10/2000CA2358589A1 Method for predicting fiber length using qtl's and molecular markers
08/09/2000WO2000052043A1 Polypeptide having antihuman immunodeficiency virus activity, gene encoding the polypeptide and process for producing the polypeptide
08/09/2000EP1026263A2 Oligonucleotide reverse transcription primers for efficient detection of HIV-1 and HIV-2 and methods of use thereof
08/09/2000EP1026262A2 Oligonucleotide primers for efficient detection of hepatitis C virus (HCV) and methods of use thereof
08/09/2000EP1026261A2 Enhancement of the specificity of nucleic acid amplification by carrier nucleic acid
08/09/2000EP1026260A1 Simultaneous measurement of gene expression and genomic abnormalities using nucleic acid microarrays
08/09/2000EP1026258A2 Multiplex genotyping of populations of individuals
08/09/2000EP1026256A2 Method for the production of optically active cyanohydrins
08/09/2000EP1026253A2 Expression of exogenous polynucleotide sequences in a vertebrate
08/09/2000EP1026252A1 Synthetic gene of bovine viral diarrhoea virus
08/09/2000EP1026251A2 Transgenic animals expressing human P25
08/09/2000EP1026250A1 DNA-constructs of blood clotting factors and P-selectin
08/09/2000EP1026249A1 GENE ENCODING alpha-SUBUNIT OF RICE ANTHRANILATE SYNTHASE AND DNA RELATING THERETO
08/09/2000EP1026248A2 Gene cluster
08/09/2000EP1026246A1 Avian infectious herpesvirus recombinants and recombinant vaccines prepared with the use of the same
08/09/2000EP1026245A1 Antigen protein and nucleic acid coding for said protein
08/09/2000EP1026244A1 Proteins Capable of Triggering G2/M transition and of Interacting with CDC2- and Cyclin B
08/09/2000EP1026243A1 NUCLEIC ACID CAPABLE OF BINDING SPECIFICALLY TO Ras TARGET PROTEIN
08/09/2000EP1026242A1 METHOD FOR SCREENING FULL-LENGTH cDNA CLONES
08/09/2000EP1026241A1 An improved method for preparing DNA from serum and plasma
08/09/2000EP1026240A2 Generation and selection of recombinant varied binding proteins
08/09/2000EP1026239A2 A new method for tapping the immunological repertoire
08/09/2000EP1026238A2 Cloned glutamic acid decarboxylase
08/09/2000EP1026237A2 Tau/neurofilament protein kinases pk40 & pk36
08/09/2000EP1026173A1 Antihuman thymidylate synthase monoclonal antibodies and hybridomas producing the same
08/09/2000EP1025902A2 Apparatus and method for polymer synthesis using arrays